CDPH Home Health License in Orange County

This home health agency license (no PTAN) is a rare and strategic opportunity for experienced healthcare operators looking to enter or expand in the California home health market. The agency is structured as a California LLC, serving a broad Geographic Service Area including LA, Orange, Riverside, San Bernardino, and San Diego counties. The agency is active and compliant, with the next state department of health license renewal due January 30, 2027. The business does not fall under the 36-month Medicare rule, providing assurance of regulatory compliance and operational readiness. The buyer will need to go through an accreditation survey to obtain their PTAN. This opportunity allows a qualified buyer to immediately leverage the business and infrastructure to operate in multiple counties. While the current census is zero, the business maintains a pristine compliance record with no liens, ADRs, or billing issues. The sale is ideal for a buyer with healthcare experience who can generate patient referrals, manage operations, and expand in a competitive and growing home health market. The seller will provide guidance during the transition, including reviewing operational procedures, licensing protocols, and strategic advice to support the buyer's launch and growth in this market. The seller is not offering SBA 7(a) loans or seller financing and prefers an all-cash transaction; however, all reasonable offers will be considered. Seller Preferences: Preference will be given to buyers who have demonstrable experience in the healthcare industry, including prior ownership or operational management of a similar healthcare agency. Buyers must provide verifiable Proof of Funds confirming their financial capacity to complete the transaction. Additionally, buyers should have access to established patient referral sources and a network of licensed and qualified healthcare professionals required to operate the business in compliance with all applicable laws and regulations. The seller will not consider SBA 7(a) financing or seller financing options and seeks an all-cash buyer. All reasonable offers will be evaluated. Confidential information will be disclosed only after the execution of a Non-Disclosure Agreement (NDA) and receipt of satisfactory Proof of Funds. Seller Recommendations: Prospective buyers should demonstrate the ability to generate patient referrals, maintain access to qualified healthcare professionals, and engage independent advisors, including legal, accounting, and regulatory consultants, to support due diligence and the transaction review process. Buyer Requirements: All prospective buyers must execute a Non-Disclosure Agreement (NDA) and provide Proof of Funds prior to receiving any confidential or non-public information. Failure to meet these requirements may result in disqualification from further consideration. Due Diligence: The Confidential Information Memorandum (CIM) is provided for preliminary review purposes only. Access to information beyond the CIM will be granted solely upon execution of a bona fide Purchase Agreement that is acceptable to the seller. Any further due diligence will be governed exclusively by the terms of that agreement. Disclaimer: All information provided is sourced from the seller and is the seller's sole responsibility. Healthcare Biz Brokers, Inc., its agents, representatives, and affiliates, make no representations or warranties, express or implied, regarding the accuracy, completeness, or reliability of any information provided. Prospective buyers are encouraged to conduct their own independent due diligence and consult with qualified legal, accounting, and regulatory advisors. All agreements, contracts, and legal documents related to the transaction should be independently reviewed by each party's legal counsel prior to execution. Healthcare Biz Brokers, Inc. does not provide legal advice, interpret documents, assess enforceability, or guarantee any aspect of the transaction. Buyers are advised to verify all due diligence matters independently. For hospice acquisitions, a Third-Party CAP (Aggregate Cap) Analysis is recommended as part of the buyer's due diligence process.